Retinal Vascular Fractals Correlate With Early Neurodegeneration in Patients With Type 2 Diabetes Mellitus by Frydkjaer-Olsen, Ulrik et al.
Syddansk Universitet
Retinal Vascular Fractals Correlate With Early Neurodegeneration in Patients With
Type 2 Diabetes Mellitus
Frydkjær-Olsen, Ulrik; Hansen, Rasmus Søgaard; Pedersen, Knud; Peto, Tunde ; Grauslund,
Jakob
Published in:






Publisher's PDF, also known as Version of record
Citation for pulished version (APA):
Frydkjaer-Olsen, U., Soegaard Hansen, R., Pedersen, K., Peto, T., & Grauslund, J. (2015). Retinal Vascular
Fractals Correlate With Early Neurodegeneration in Patients With Type 2 Diabetes Mellitus. Investigative
Ophthalmology & Visual Science, 56(12), 7438-7443. DOI: 10.1167/iovs.15-17449
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 09. Sep. 2018
Retina
Retinal Vascular Fractals Correlate With Early
Neurodegeneration in Patients With Type 2 Diabetes
Mellitus
Ulrik Frydkjaer-Olsen,1,2 Rasmus Soegaard Hansen,1,2 Knud Pedersen,1,2 Tunde Peto,2,3
and Jakob Grauslund1,2
1Department of Ophthalmology, Odense University Hospital, Odense, Denmark
2Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
3The NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology,
London, United Kingdom
Correspondence: Ulrik Frydkjaer-Ol-
sen, Department of Ophthalmology,
Odense University Hospital, Sdr.
Boulevard 29, DK-5000 Odense C,
Denmark;
ulrik.frydkjaer-olsen@rsyd.dk.
Submitted: June 9, 2015
Accepted: October 12, 2015
Citation: Frydkjaer-Olsen U, Soegaard
Hansen R, Pedersen K, Peto T, Graus-
lund J. Retinal vascular fractals corre-
late with early neurodegeneration in
patients with type 2 diabetes mellitus.
Invest Ophthalmol Vis Sci.
2015;56:7438–7443. DOI:10.1167/
iovs.15-17449
PURPOSE. To investigate the correlation between the retinal vascular fractal dimension (Fd) and
neurodegenerative changes in patients with no or mild diabetic retinopathy (DR).
METHODS. In this cross-sectional study we examined 103 patients with type 2 diabetes mellitus
(T2DM) with no or mild DR. In a randomly selected eye of each patient, Fd was calculated
using SIVA-Fractal, a specialized semiautomatic software. Retinal neurodegeneration was
evaluated by Topcon 3D OCT-2000 spectral-domain optical coherence tomography (OCT) and
by a RETI-scan multifocal ERG (mf-ERG) system in rings one to six. Level of DR was
determined by a single trained grader in seven-field fundus photos according to the Early
Treatment Diabetic Retinopathy Study (ETDRS) scale.
RESULTS. Mean age and duration of T2DM were 62.3 and 11.6 years, respectively; 46.6% were
men. Mean Fd was 1.413 (range, 1.278–1.509) and ETDRS levels were 10 (42.7%), 20 (35.0%),
and 35 (22.3%), respectively. Fd correlated inversely with mf-ERG implicit time of ring one (r
¼ 0.25, P ¼ 0.01) and present diabetic neuropathy (P ¼ 0.02), and positively with OCT
ganglion cell layer (GCL) thickness (r ¼ 0.20, P ¼ 0.04). In a multivariable linear regression
model, Fd was associated with mf-ERG implicit time of ring one (coefficient 0.0021/ms, P ¼
0.040) and the presence of diabetic neuropathy (coefficient 0.0209 for neuropathy present
versus absent, P ¼ 0.041).
CONCLUSIONS. In patients with T2DM and no or minimal DR, independent correlations were
found between early vascular and neurogenic changes. Thus, retinal vascular fractal analysis
might be considered as a tool to identify patients with early neurodegenerative retinal
changes.
Keywords: diabetic retinopathy, neurodegeneration, retinal vascular fractal, retinal
vasculature, image analysis
The prevalence of patients with type 2 diabetes mellitus(T2DM) is rising.1 Diabetic retinopathy (DR) is a potentially
sight-threatening complication. Identification of subtle changes
in the early stages of DR is important to identify patients who
are most likely to develop long-term proliferative DR (PDR) and
diabetic macular edema.2
For many years DR has been described as a microvascular
disease, but several studies now indicate evidence of a
neurodegenerative factor with impact on the development of
the disease.35 Even in patients with no or minimal DR there is
evidence of retinal neurodegeneration with glial activation and
apoptosis in the ganglion cell layer (GCL).68 In addition to the
structural changes, there is also evidence of functional changes
as measured by multifocal ERG (mf-ERG).9 The structural
composition of the neuroretina can be measured by the
thickness of macular GCL by optical coherence tomography
(OCT).8 These advanced techniques allow the examination of
subtle neurodegenerative changes and provide valuable knowl-
edge about the pathophysiology in early DR.
The availability of computer-based software allows us to
assess the geometric features of the retinal blood vessels.
Retinal vascular fractal analysis quantifies the fractal pattern of
the retinal vascular tree.10 Fractal patterns, a common
phenomenon in nature, are also seen in branching structures,
such as frost crystals, tree branches, and lightning. Fractal
structures are characterized by a self-similar pattern that is
unaffected by difference in magnification. That is, under
different magnification, a smaller part of the whole will have
the same structure as the larger part.
Retinal vascular fractal analysis is a validated method to
describe the density and complexity of the retinal vascular tree
in one parameter: the retinal vascular fractal dimension (Fd).11
Fd is defined as a noninteger unit between 1 and 2 that
increases correspondingly to the density of the retinal vascular
tree.
In previous studies, Fd was correlated to and predictive of
microvascular complications in type 1 diabetes patients.12,13
However, as far as we know, the relation between the Fd and
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neurodegenerative changes has never been examined in
diabetes.
The aim of the present study was to associate the Fd with
retinal neurodegeneration and diabetic neuropathy in a cross-
sectional study of patients with T2DM and no or minimal DR.
METHODS
Study Population
We examined 105 patients with T2DM between 1 April 2013
and 1 July 2014 at Odense University Hospital, Odense,
Denmark. The patients were recruited from the local DR
screening clinic. Only T2DM patients with no or minimal DR
were invited. Further inclusion criteria were age between 45
and 75 years and duration of T2DM more than 5 years. Patients
previously diagnosed with glaucoma were excluded, due to
possible existing neurodegenerative changes.
The study was performed in accordance with the principles
of the Helsinki II Declaration. Approval from the regional
scientific ethical committees for Southern Denmark was
obtained before patient examinations, and all patients gave
written informed consent.
Study Examinations
The patients provided a full medical history, including
information about age, sex, diabetes duration, and presence
of complications, such as diabetic nephropathy and neuropa-
thy. Diabetic neuropathy was defined by hypoesthesia in the
peripheral part of the extremities as questioned by the
examiner or as self-reported by the patient (for those already
diagnosed). The HbA1c, triglyceride, cholesterol, creatinine,
and glomerular filtration rate were measured from a blood
sample obtained at the time of the ophthalmic examination. A
urine sample was also retrieved so as to reveal any presence of
albuminuria. Additionally, the albumin-creatinine ratio was
calculated. Blood pressure was measured one time using an
Omron M4 monitor (Omron Matsusaka Co., Matsusaka, Japan)
with the patient at rest in a seated position. Body mass index
was calculated from measurement of height and weight (lightly
clothed).
Retinal Analysis
Pupils were dilated with tropicamide (10 mg/mL) and
phenylephrine (10%). A Topcon TRC-NW6S (Topcon, Tokyo,
Japan) was used to acquire 30-degree seven-field color fundus
photographs of both eyes according to the modified Early
Treatment Diabetic Retinopathy Study (ETDRS) seven standard
fields. Level of DR was determined by a single certified grader
(UF) from the seven-field color fundus photographs using the
ETDRS scale.14
Retinal vascular fractal analysis was evaluated from a disc-
centered cropped Optos 200Tx image (Optos plc, Dunferm-
line, Scotland, UK) (Fig. 1). In a randomly selected eye of each
patient, Fd was calculated by a specialized semiautomatic
software: SIVA-Fractal (Singapore Institute Vessel Assessment-
Fractal, version 1.0; School of Computing, National University
of Singapore, Singapore).15 The software automatically detect-
ed the optic disc and traced vessels in a zone 0.5 to 2.0 disc
diameter from the disc margin (Fig. 2). A trained grader (KP)
then compared the automated vessel tracing with the color
fundus photographs and removed any artifacts traced as
vessels. The box-counting method by SIVA-fractal was used to
assess the Fd.1618 Fractal analysis is a validated and reliable
method to describe the retinal vasculature and studies have
previously shown excellent intra- and intergrader reliabili-
ty.11,15
Topcon 3D OCT-2000 spectral-domain OCT (Topcon) was
used to measure the thickness of the GCL in the macula region.
The thickness of the retinal nerve fiber layer (RNFL) at the
optic disc and the thickness of retina from the internal limiting
membrane to the RPE in the macula region were also
measured. Thicknesses of the different layers were measured
automatically by the Topcon 3D OCT-software (Topcon OCT
Viewer, Version 6.7; Topcon). Each scan was centered and
without or less than 10% cropping. The image quality of each
scan was as high as possible and the OCT B-scan equal color
FIGURE 1. The fractal pattern of the retinal vascular tree and a disc-centered cropped Optos 200Tx image.
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density. The OCT en face image was well aligned to the
underlying fundus image and without saccades through macula
and optic nerve.
The RETI-scan mf-ERG system (Roland Consult; Branden-
burg a.d., Havel, Germany) in rings one to six was used based
on the International Society for Clinical Electrophysiology of
Vision standard for clinical multifocal electroretinography
(2011 edition).19 The examined retinal area with the macula
in the center corresponded to 46.4 degrees and was arranged
in 103 hexagons. The mf-ERG amplitude and implicit time of
rings one to six, with ring one being the central area, was
calculated by the RETI-scan software.
Statistical Methods
Statistical analyses were performed with STATA 13 (StataCorp
LP, College Station, TX, USA), and a P less than 0.05 was
considered statistically significant. Categorical data are pre-
sented as percentages and continuous data are presented as
means (with range). To study possible associations between
two continuous variables, Pearson’s r correlation coefficient
was used. Kruskal-Wallis equality of proportions rank test was
used to test for differences in continuous data between groups.
Associations from univariate analysis with P less than 0.05
were subsequently used in a multivariable linear regression
model adjusted for potential confounders with Fd as the
dependent variable. Multivariable linear regression model was
used to identify significant independent factors with correla-
tion to the Fd.
RESULTS
A total of 105 patients were examined. It was not possible to
perform fractal analysis in one patient (due to asteroid hyalosis
in both eyes), and one patient had missing data from the mf-
ERG and OCT examination. For the remaining 103 patients, the
mean age and duration of T2DM were 62.3 and 11.6 years,
respectively; 46.6% were men. Mean Fd was 1.413 (range,
1.278–1.509), and ETDRS levels were 10/DR absent (42.7%),
20/microaneurysms only (35.0%), and 35/mild nonproliferative
DR (22.3%), respectively (Table 1).
In univariate analysis, we found a negative correlation
between Fd and mf-ERG implicit time of ring one (r¼0.25, P
¼ 0.01) (Fig. 3, Table 2). Fd was positively correlated to the
GCL thickness of the macula region (r¼0.20, P¼0.04) (Fig. 4),
and a lower Fd was associated with the presence of diabetic
neuropathy (P ¼ 0.02) (Fig. 5). There were no statistically
significant correlations between Fd and age, sex, duration of
diabetes, blood pressure, body mass index, nephropathy, or
any other OCT and mf-ERG parameters.
In a multivariable linear regression model adjusted for age,
sex, diabetes duration, HbA1c, systolic and diastolic blood
pressure, and presence of DR, Fd was associated inversely with
mf-ERG implicit time of ring one (coefficient 0.0021 per
millisecond increase of implicit time, P ¼ 0.040) and diabetic
neuropathy (coefficient0.0209 for neuropathy being present
versus absent, P ¼ 0.041) (Table 2). In separate multivariable
regression analysis in patients with no DR (n ¼ 44) and in
patients with mild DR (n ¼ 59), respectively, there was no
statistically significant correlation between Fd and any of the
covariates tested in Table 2.
In clinical terms, each millisecond prolongation of the
implicit time of ring one in mf-ERG was associated with a
FIGURE 2. The SIVA-fractal analysis with an image of the grid.
FIGURE 3. Correlation between implicit time of ring one and Fd among
103 patients with T2DM and minimal or no DR (r¼0.25, P¼ 0.011).
FIGURE 4. Correlation between GCL thickness in the macula and Fd
among 103 patients with T2DM and minimal or no DR (r ¼ 0.20, P ¼
0.041).
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decrease in Fd of 0.0021 and the presence of diabetic
neuropathy was correlated with a decrease in Fd of 0.0209.
In univariate analysis, mf-ERG amplitude of rings one to six
was positively correlated to the GCL thickness of the macula
region (r¼ 0.21–0.26, P¼ 0.01–0.03) and mf-ERG implicit time
of ring three was positively correlated to the GCL thickness of
the macula region (r ¼ 0.24, P ¼ 0.01) (data not shown).
However, we found no statistically significant correlations
between mf-ERG implicit time of the other rings and GCL
thickness of the macula region.
DISCUSSION
In this study of T2DM patients with no or early DR, we found
that the Fd correlated independently and inversely with the
implicit time of ring one mf-ERG as well as the presence of
diabetic neuropathy. Fd was associated with the thickness of
the macular GCL in univariate analysis.
Previous studies that included patients with T2DM have
investigated the correlation between Fd and vascular param-
eters, such as retinal blood flow20 and the development of
PDR.21 Most clinical studies measuring Fd have included
patients with type 1 diabetes mellitus,12,13,2224 patients with
increased levels of HbA1c,25,26 or examined data from patients
with diabetes who developed DR over time.2729
In a cross-sectional study, Grauslund et al.12 found an
independent correlation between lower Fd and the presence
of inactive PDR as well as neuropathy. Broe et al.13 expanded
these findings in a 16-year prospective study in which lower Fd
independently was able to predict all types of microvascular
impairment (inactive PDR, nephropathy, and neuropathy).
These findings support our results as we also found a
significant correlation between a lower Fd and the presence
of diabetic neuropathy.
In a population-based cross-sectional study of 352 patients,
Tham et al.30 examined Fd in relation to retinal neurodegen-
erative changes in nonglaucomatous eyes. Although the study
population was not solely patients with diabetes mellitus, the
results were partly consistent with our findings that decreased
Fd was associated with a thinner peripapillary RNFL and
macular ganglion cell–inner plexiform layer thickness after
adjustment for age and sex. The later result corresponds to the
finding in our study using univariate analysis. However, the
association between Fd and GCL thickness was not significant
when adjusted for several variables in the multivariable model
(P ¼ 0.14). In the present study, we did not find a correlation
between Fd and RNFL (P ¼ 0.13). Moreover, the statistically
significant correlations between Fd and neurodegenerative
parameters in multivariable linear regression model were not
present in separate regression analysis that included only
patients with/without DR. We suspect these findings were
FIGURE 5. Correlation between neuropathy being present or absent
and Fd among 103 patients with T2DM and minimal or no DR (P ¼
0.016).
TABLE 1. Clinical Characteristics of the Examined Patients With T2DM
Characteristic Mean Range
Age, y 62.3 47.9–70.3
Sex, % male 46.6
Duration of diabetes, y 11.6 6–26
HbA1c, mmol/mol 54.3 36–99
Systolic blood pressure, mm Hg 134 98–177
Diastolic blood pressure, mm Hg 80 58–102
Body mass index, kg/m2 31 22–53
Mf-ERG implicit time of ring one, ms 41.2 31.4–48
Thickness of GCL in macula, lm 67.2 47–82
DR present, % 57.3
Diabetic neuropathy present, % 20
Fd 1.413 1.278–1.509





P Coefficient (95% CI) P
Age, per y 0.114 0.0009 (0.0024 to 0.0007) 0.271
Sex, male 0.414 0.0077 (0.0088 to 0.0242) 0.358
Duration of diabetes, per y 0.881 0.0001 (0.0019 to 0.0018) 0.918
HbA1c, per mmol/mol 0.229 0.0005 (0.0011 to 0.0002) 0.166
Systolic blood pressure, per 10 mm Hg 0.884 0.0012 (0.0048 to 0.0072) 0.690
Diastolic blood pressure, per 10 mm Hg 0.697 0.00004 (0.0111 to 0.0110) 0.995
Mf-ERG implicit time of ring one, per ms 0.011* 0.0021 (0.0040 to 0.0001) 0.040*
Thickness of GCL in macula, per lm 0.041* 0.0010 (0.0003 to 0.0023) 0.136
DR, present 0.626 0.0011 (0.0159 to 0.0180) 0.898
Diabetic neuropathy, present 0.016* 0.0209 (0.0410 to 0.0009) 0.041*
Constant 1.4976 (1.3241 to 1.6711)
Model includes age, sex, duration of diabetes, HbA1c, blood pressure (systolic and diastolic), DR, mf-ERG implicit time of ring one, GCL
thickness in the macula, and diabetic neuropathy.
* Statistically significant (P < 0.05).
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caused by a small sample size in each group. Nevertheless, the
significant findings support our hypothesis of retinal neurode-
generative changes being present despite no or minimal visible
vascular morphological changes secondary to DR.
Diabetic peripheral neuropathy (DPN) and retinal neurode-
generative changes are different in an anatomical perspective:
DPN is a disease of the peripheral nervous system and retinal
ganglion cells form the second cranial nerve. Hence, retinal
neurodegeneration is defined as a disease located to the central
nervous system.31 Given the fact that both diseases have an
early onset in patients with diabetes, we speculate that
similarities in the pathophysiological pathway might be found.
One of them being a neurovascular coupling and the other that
they both belong to microvascular complications of T2DM. We
speculate that diabetic neuropathy develops over time by some
of the same mechanisms as DR, partly driven by the glycemic
load. However, the significant correlation between Fd and the
neurodegenerative changes in our study remained consistent
despite adjustments for HbA1c and duration of diabetes.
Therefore, we hypothesize that other mechanisms might play
a significant role as well.
Several studies have examined the association between mf-
ERG and DR. To our knowledge, no other study has examined
the association between Fd and mf-ERG implicit time in
patients with T2DM. A few studies found evidence that mf-ERG
implicit time can predict development of DR.9,32 They found
that areas with prolonged mf-ERG implicit time in eyes without
DR can predict DR lesions. The finding corresponds with our
result that retinal neurodegenerative changes (mf-ERG implicit
time delays) are associated with subtle changes in the retinal
vasculature; a decreased Fd.
To examine the relation between functional and structural
neurodegenerative parameters, we correlated the mf-ERG
parameters (functional marker) to GCL thickness of the macula
region (structural marker). The mf-ERG amplitude of rings one
to six was positively correlated to the GCL thickness of the
macula region. This indicates that patients with a strong
electrical signal were more likely to have increased GCL
thickness. The correlation between mf-ERG amplitude and
GCL thickness of the macula region in patients with T2DM, to
our knowledge, is a novel finding.
Surprisingly, we also found a positive correlation between
mf-ERG implicit time of ring three and GCL thickness. There
were no correlations between the implicit time of the other
rings and GCL thickness. Physiologically, we would have
expected a negative correlation with prolonged implicit time
associated with GCL atrophy. This indicates that the positive
correlation between ring three implicit time and GCL thickness
could be caused by mass significance due to the multiple
comparisons tested.
There is a variance in quantitative measurements with
spectral-domain OCT images that may affect the accuracy of
GCL thickness measurement.33 The cross-sectional design of
this study prevents any prospective analysis of microvascular
and neurodegenerative changes. Nonetheless, the clinical
features of the T2DM patients (all with no or minimal DR)
enabled the opportunity to examine and determine clinically
subtle changes in early DR in an ethnically homogeneous
Caucasian population.
In conclusion, Fd correlated significantly both with
functional and structural neurodegenerative changes in the
retina and was associated with the presence of diabetic
neuropathy. We suggest that future prospective clinical studies
examining novel treatment for arresting or preventing early DR
include fractal analysis to identify subtle changes in the retinal
vasculature.
The fractal pattern of the retinal vascular tree may give
valuable information about the presence of neurodegenerative
changes in patients with T2DM, even in patients with no or
early stages of DR.
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